Effects of a novel platelet nitric oxide donor (LA816), aspirin, clopidogrel, and combined therapy in inhibiting flow- and lesion-dependent thrombosis in the porcine ex vivo model
about
sameAs
A comprehensive study on different modelling approaches to predict platelet deposition rates in a perfusion chamber.In the presence of strong P2Y12 receptor blockade, aspirin provides little additional inhibition of platelet aggregation.Blockade of the purinergic P2Y12 receptor greatly increases the platelet inhibitory actions of nitric oxide.Atherosclerosis and thrombosis: insights from large animal models.Monomerization of C-reactive protein requires glycoprotein IIb-IIIa activation: pentraxins and platelet deposition.
P2860
Effects of a novel platelet nitric oxide donor (LA816), aspirin, clopidogrel, and combined therapy in inhibiting flow- and lesion-dependent thrombosis in the porcine ex vivo model
description
2004 nî lūn-bûn
@nan
2004 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Effects of a novel platelet ni ...... s in the porcine ex vivo model
@ast
Effects of a novel platelet ni ...... s in the porcine ex vivo model
@en
Effects of a novel platelet ni ...... s in the porcine ex vivo model
@nl
type
label
Effects of a novel platelet ni ...... s in the porcine ex vivo model
@ast
Effects of a novel platelet ni ...... s in the porcine ex vivo model
@en
Effects of a novel platelet ni ...... s in the porcine ex vivo model
@nl
prefLabel
Effects of a novel platelet ni ...... s in the porcine ex vivo model
@ast
Effects of a novel platelet ni ...... s in the porcine ex vivo model
@en
Effects of a novel platelet ni ...... s in the porcine ex vivo model
@nl
P921
P1433
P1476
Effects of a novel platelet ni ...... s in the porcine ex vivo model
@en
P2093
Gemma Vilahur
P304
P356
10.1161/01.CIR.0000142296.19558.99
P407
P577
2004-09-01T00:00:00Z